Skip to main content
Caplight Logo









Ancora Heart

Ancora Heart

Private
Santa Clara, CaliforniaHealthcare & Life Scienceshttps://www.ancoraheart.com/

Last Round

VC Round

Jul 19, 2021

Total Funding Raised

$64M

Company Overview

Ancora Heart is a medical device company that develops a percutaneous ventricular restoration system aimed at treating heart failure by addressing left ventricular dysfunction, reducing its size, and enhancing heart wall support to improve patients' quality of life.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

ventricular restorationtranscatheter heart implantheart failure deviceheart failure treatmentminimally invasive cardiologyAccuCinchcatheter-based therapycardiac deviceinterventional cardiologyFDA breakthrough devicepivotal clinical trialstructural heartmedtech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Ancora Heart Comparables

Compare Ancora Heart with similar companies based on industry and business-model similarity.

Ancora Heart comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
BioVentrix
86%
Cardiac Success
86%
Corvia Medical
85%

Ancora Heart Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundJul 19, 2021
Series BMay 30, 2018
Series BApr 28, 2010
Series AFeb 6, 2008

Ancora Heart Investors

Notable investors and investment history

Ancora Heart investors
InvestorRounds
Sio Capital ManagementVC Round
Ascent Biomedical VenturesSeries A
Savitr CapitalVC Round, Series B
Sands CapitalVC Round

Ancora Heart Filings

Explore SEC and related filing metadata, where available.

Ancora Heart filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Ancora Heart's valuation, stock price, and market status.

Is Ancora Heart a public or private company?

Ancora Heart is a private company.

What is the current stock price of Ancora Heart?

Ancora Heart is a private company with no public stock price. No recent secondary market data is available.

How much is Ancora Heart worth (valuation)?

Valuation information for Ancora Heart is not publicly available.

Can I buy Ancora Heart stock?

Ancora Heart shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Ancora Heart's last funding round?

Ancora Heart's most recent funding round was Series D on July 19, 2021.

Who are the main investors in Ancora Heart?

Key investors in Ancora Heart include Savitr Capital, Sands Capital.

Will Ancora Heart IPO soon?

No public IPO plans have been announced for Ancora Heart.

How can I track Ancora Heart secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Ancora Heart's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSanta Clara, California
Employee Range56
Year Founded2001
Last FundingJul 19, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?